4.6 Article

Flame-Made Calcium Phosphate Nanoparticles with High Drug Loading for Delivery of Biologics

Journal

MOLECULES
Volume 25, Issue 7, Pages -

Publisher

MDPI
DOI: 10.3390/molecules25071747

Keywords

nanocarriers; drug delivery; biologics; calcium phosphate; flame spray pyrolysis; LL-37; stability; antimicrobial properties

Funding

  1. European Research Council (ERC) [758705]
  2. Karolinska Institutet Board of Research
  3. Swedish Research Council [2016-03471, 2016-00228, 2016-01861, 2018-05798]
  4. Jeansson Foundations [JS2016-0029]
  5. Torsten Soderberg Foundation [M87/18]
  6. Swedish Foundation for Strategic Research (SSF), Stockholm County Council
  7. Knut and AliceWallenberg Foundation
  8. Swedish Research Council [2016-00228, 2016-03471, 2016-01861, 2018-05798] Funding Source: Swedish Research Council
  9. Formas [2016-00228] Funding Source: Formas

Ask authors/readers for more resources

Nanoparticles exhibit potential as drug carriers in biomedicine due to their high surface-to-volume ratio that allows for facile drug loading. Nanosized drug delivery systems have been proposed for the delivery of biologics facilitating their transport across epithelial layers and maintaining their stability against proteolytic degradation. Here, we capitalize on a nanomanufacturing process famous for its scalability and reproducibility, flame spray pyrolysis, and produce calcium phosphate (CaP) nanoparticles with tailored properties. The as-prepared nanoparticles are loaded with bovine serum albumin (model protein) and bradykinin (model peptide) by physisorption and the physicochemical parameters influencing their loading capacity are investigated. Furthermore, we implement the developed protocol by formulating CaP nanoparticles loaded with the LL-37 antimicrobial peptide, which is a biological drug currently involved in clinical trials. High loading values along with high reproducibility are achieved. Moreover, it is shown that CaP nanoparticles protect LL-37 from proteolysis in vitro. We also demonstrate that LL-37 retains its antimicrobial activity against Escherichia coli and Streptococcus pneumoniae when loaded on nanoparticles in vitro. Therefore, we highlight the potential of nanocarriers for optimization of the therapeutic profile of existing and emerging biological drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available